The use of isotretinoin-based preparations for the combined treatment of acne vulgaris

Mokhammad S.; Kuzina Z.A.; Voloshin R.N.

doi:https://doi.org/

Mokhammad S.

Rostov State Medical University, Rostov-on-Don

Kuzina Z.A.

Rostov State Medical University, Rostov-on-Don

Voloshin R.N.

Rostov State Medical University, Rostov-on-Don

The use of isotretinoin-based preparations for the combined treatment of acne vulgaris

Authors:

Mokhammad S., Kuzina Z.A., Voloshin R.N.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2011;9(4): 71‑74

Read: 4602 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Mokhammad S, Kuzina ZA, Voloshin RN. The use of isotretinoin-based preparations for the combined treatment of acne vulgaris. Russian Journal of Clinical Dermatology and Venereology. 2011;9(4):71‑74. (In Russ.)

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Study of the role of interleukin-1β in blood serum in patients with acne. Russian Journal of Clinical Dermatology and Venereology. 2025;(4):421-424

Adherence of patients to acne therapy using systemic isotretinoin. Russian Journal of Clinical Dermatology and Venereology. 2025;(4):483-488

Clinical discussion of patients with follicular occlusion syndrome and comorbid pathology. Russian Journal of Clinical Dermatology and Venereology. 2025;(5):596-603

Rational choice of combined therapy of acne: systemic isotretinoin and high-energy hardware technologies. Russian Journal of Clinical Dermatology and Venereology. 2025;(5):651-656

Acne conglobata and acne fulminans. Russian Journal of Clinical Dermatology and Venereology. 2025;(5):666-674

Relationship between acne and obesity: modern possibilities of therapy with metformin and isotretinoin in Lidose technology. Russian Journal of Clinical Dermatology and Venereology. 2026;(1):84-84

Clinical, pharmacological and legal validity of the use of combined topical agents for acne treatment in the practice of dermatologist. Russian Journal of Clinical Dermatology and Venereology. 2026;(1):96-103

Efficacy and safety of injectable complex of stabilized and native hyaluronic acid and sorbitol for lip skin hydration in patients taking systemic retinoids. Plastic Surgery and Aesthetic Medicine. 2025;(3):64-70

Abstract:

Keywords:

acne

isotretinoin Lidose

Acnecutan

adapalene

Authors:

Mokhammad S.

Rostov State Medical University, Rostov-on-Don

Kuzina Z.A.

Rostov State Medical University, Rostov-on-Don

Voloshin R.N.

Rostov State Medical University, Rostov-on-Don

Close metadata

References:

Goodman G.J., Baron J.A. The management of postacne scarring. Dermatol Surg 2007;33:10:1175-1188.
Mallon E., Newton J.N., Klassen A. et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999;140:4:672-676.
Cooper A.J. Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med J Aust 1998;169:5:259-261.
Grosshans E., Marks R., Mascaro J.M. et al. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol 1998;139:Suppl 52:26-33.
Kellett S.C., Gawkrodger D.J. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999;140:2:273-282.
Collier C.N., Harper J.C., Cafardi J.A. et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008;58:1:56-59.
Percy S.H. Safety and efficacy of adapalene gel 0,1% in acne vulgaris: results of a post-marketing surveillance study. Indian J Dermatol Venereol Leprol 2003;69:4:277-280.
Gollnick H., Cunliffe W., Berson D. et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003;49:1:Suppl:S1-S37.
Amichai B., Shemer A., Grunwald M.H. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol 2006;54:4:644-646.
Baker M., Tuley M., Busdiecker F.L. et al. Adapalene gel 0.1% is effective and well tolerated in acne patients in a dermatology practice setting. Cutis 2001;68:4:Suppl:41-47.
Sardana K., Garg V.K., Sehgal V.N. et al. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris. J Eur Acad Dermatol Venereol 2009;23:5:556-560.
Leyden J.J., McGinley K.J., Cavalieri S. et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983;8:1:41-45.
Leyden J.J., Marples R.R., Mills O.H., Kligman A.M. Tretinoin and antibiotic therapy in acne vulgaris. South Med J 1974;67:1:20-25.
Thiboutot D.M, Weiss J, Bucko A. et al. Adapalene-bezoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results from a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol 2007;57:5:791-799.
Cunliffe W.J., Meynadier J., Alirezai M. et al. Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle. J Am Acad Dermatol 2003;49:3:Suppl:S218-S226.
Millikan L.E. Pivotal clinical trials of adapalene in the treatment of acne. J Eur Acad Dermatol Venereol 2001;15:Suppl 3:19-22.
Mills O.H. Jr., Kligman A.M. Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Derm Venereol 1978;58:6:555-557.